YARROW BIOSCIENCE, INC. (YARW) Gross Margin
- Gross margin · 12 months: Value (m); Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | (m) | Gross profit / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | (m) | |
| Revenue | 482.00K USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | (m) | $482.00K | (m) | (m) |
| 2026-03-31 | (m) | $454.00K | (m) | (m) |
| 2025-12-31 | (m) | $570.00K | (m) | (m) |
| 2025-06-30 | (m) | $476.00K | (m) | (m) |
| 2025-03-31 | (m) | $605.00K | (m) | (m) |
| 2024-12-31 | (m) | $501.00K | (m) | (m) |
| 2024-09-30 | (m) | $493.00K | (m) | (m) |
| 2024-06-30 | (m) | $486.00K | (m) | (m) |
| 2024-03-31 | (m) | $423.00K | (m) | (m) |
| 2023-12-31 | (m) | $424.00K | (m) | (m) |
| 2023-09-30 | (m) | $354.00K | (m) | (m) |
| 2023-06-30 | (m) | $407.00K | (m) | (m) |
| 2023-03-31 | (m) | $398.00K | (m) | (m) |
| 2022-12-31 | (m) | $477.00K | (m) | (m) |
| 2022-09-30 | (m) | $14.57M | (m) | (m) |
| 2022-06-30 | (m) | $14.53M | (m) | (m) |
| 2022-03-31 | (m) | $14.70M | (m) | (m) |
| 2021-12-31 | (m) | $14.76M | $3.35M | (m) |
| 2021-09-30 | (m) | $16.75M | $2.98M | (m) |
| 2021-06-30 | (m) | $15.93M | $2.30M | (m) |
| 2021-03-31 | (m) | $23.36M | $1.72M | (m) |
| 2020-12-31 | (m) | $20.99M | $1.39M | (m) |
| 2020-09-30 | (m) | $16.40M | (m) | (m) |
| 2020-06-30 | (m) | $13.13M | (m) | (m) |
| 2020-03-31 | (m) | $1.44M | (m) | (m) |
| 2019-12-31 | (m) | $0.00 | (m) | (m) |
| 2019-09-30 | (m) | $0.00 | (m) | (m) |
| 2019-06-30 | (m) | $0.00 | (m) | (m) |
| 2019-03-31 | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | $0.00 | (m) | (m) |
| 2018-09-30 | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |